1. O-001An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. (2nd July 2019) Authors: Reni, M; Riess, H; O'Reilly, E; Santoro, A; Park, J; Bekaii-Saab, T; Tempero, M; Shan, Y; Macarulla, T; Cutsem, E Van; Noel, M; Berlin, J; Biankin, A; Dhani, N; Frassineti, G; Goldstein, D; Romano, A; Bruchec, Y Le; Philip, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-002Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. (2nd July 2019) Authors: Tempero, M; Oh, D; Macarulla, T; Reni, M; Cutsem, E Van; Hendifar, A; Waldschmidt, D; Starling, N; Bachet, J; Chang, H; Maurel, J; Lonardi, S; Coussens, L; Fong, L; Tsao, L; Cole, G; James, D; Tabernero, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SO-009Phase 1 studies assessing the safety and clinical activity of autologous and allogeneic NKG2D-based CAR-T therapy in metastatic colorectal cancer. (2nd July 2019) Authors: Cutsem, E Van; Machiels, J; den Eynde, M Van; Prenen, H; Hendlisz, A; Shaza, L; Carrasco, J; Canon, J; Sotiropoulou, P; Breman, E; Alcantar, E; Flament, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗